NCT01926990View on ClinicalTrials.gov

Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 16, 2018

Study Completion Date

December 17, 2021

Conditions
Metastatic Renal Cell Cancer
Interventions
DEVICE

perfusion computed tomography

Undergo perfusion CT

Trial Locations (1)

94305

Stanford University Cancer Institute, Stanford

All Listed Sponsors
collaborator

Siemens Healthcare QT

INDUSTRY

lead

Stanford University

OTHER

NCT01926990 - Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter